(Circulation. 1997;95:1132-1137.)
© 1997 American Heart Association, Inc.
Articles |
Hypertension and Borderline Isolated Systolic Hypertension Increase Risks of Cardiovascular Disease and Mortality in Male Physicians
the Divisions of Preventive Medicine (C.J.O., P.M.R., R.J.G., K.B., U.A., J.E.M., C.H.H.) and Cardiology (C.J.O., P.M.R.), Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Cardiac Section (C.J.O.), Brockton/West Roxbury (Mass) Veterans Affairs Medical Center; the Department of Ambulatory Care and Prevention (C.H.H.), Harvard Medical School, Boston, Mass; and the Department of Epidemiology (C.H.H.), Harvard School of Public Health, Boston, Mass.
Correspondence to Dr Christopher J. O'Donnell, Framingham Heart Study, 5 Thurber St, Framingham, MA 01701. E-mail chris{at}fram.nhlbi.nih.gov
Background The objective of this study was to examine whether definite hypertension and borderline isolated systolic hypertension predict subsequent cardiovascular disease and mortality.
Methods and Results This was a prospective cohort study with a mean follow-up of 11.7 years. The subjects were a group of 18 682 apparently healthy US men, aged 40 to 84 years, participating in the Physicians' Health Study, a randomized trial of low-dose aspirin and ß-carotene. The main outcome measures were total cardiovascular disease, myocardial infarction, stroke, cardiovascular death, and all-cause mortality. Hypertension was associated with substantially increased risks of total cardiovascular disease (relative risk [RR] 1.92; 95% confidence interval [CI], 1.70 to 2.18), myocardial infarction (RR, 1.78; 95% CI, 1.49 to 2.13), stroke (RR, 2.19; 95% CI, 1.78 to 2.69), and cardiovascular death (RR, 2.10; 95% CI, 1.68 to 2.63). Borderline isolated systolic hypertension was associated with significantly increased risks of cardiovascular disease (RR, 1.32; 95% CI, 1.09 to 1.59), stroke (RR, 1.42; 95% CI, 1.04 to 1.93), and cardiovascular death (RR, 1.56; 95% CI, 1.13 to 2.15), as well as a possible but nonsignificant increased risk of myocardial infarction (RR, 1.26; 95% CI, 0.95 to 1.67). Hypertension and borderline isolated systolic hypertension were associated with significantly increased risks of 41% and 22%, respectively, for all-cause mortality.
Conclusions Hypertension as well as borderline isolated systolic hypertension are associated with elevated risks of cardiovascular diseases, especially stroke and cardiovascular death. Hypertension is associated with an increased risk of myocardial infarction, and borderline isolated systolic hypertension predicts a possible but more modest increase in risk. These data add to the existing evidence that hypertension is a major cardiovascular risk factor and extend the findings to borderline isolated systolic hypertension.
Key Words: hypertension • heart diseases • risk factors • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  O. J. Ekundayo, R. M. Allman, P. W. Sanders, I. Aban, T. E. Love, D. Arnett, and A. Ahmed Isolated Systolic Hypertension and Incident Heart Failure in Older Adults: A Propensity-Matched Study Hypertension, March 1, 2009; 53(3): 458 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cheng, C. Daskalakis, and B. Falkner Original Research: Capillary rarefaction in treated and untreated hypertensive subjects Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 79 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Femia, M. Kozakova, M. Nannipieri, C. Gonzales-Villalpando, M. P. Stern, S. M. Haffner, and E. Ferrannini Carotid Intima-Media Thickness in Confirmed Prehypertensive Subjects: Predictors and Progression Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2244 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Qureshi, M. F. K. Suri, J. F. Kirmani, A. A. Divani, and Y. Mohammad Is Prehypertension a Risk Factor for Cardiovascular Diseases? Stroke, September 1, 2005; 36(9): 1859 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Liszka, A. G. Mainous III, D. E. King, C. J. Everett, and B. M. Egan Prehypertension and Cardiovascular Morbidity Ann. Fam. Med, July 1, 2005; 3(4): 294 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Zieman, V. Melenovsky, and D. A. Kass Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 932 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Chaudhry, H. M. Krumholz, and J. M. Foody Systolic Hypertension in Older Persons JAMA, September 1, 2004; 292(9): 1074 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mason, J. E. Manson, H. D. Sesso, C. M. Albert, M. J. Chown, N. R. Cook, P. Greenland, P. M Ridker, and R. J. Glynn Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women's Antioxidant Cardiovascular Study (WACS) Circulation, April 6, 2004; 109(13): 1623 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Fox, U. Thadani, P. T.S. Ma, S. D. Nash, Z. Keating, M. A. Czorniak, H. Gillies, M. Keltai, and on behalf of the CAESAR I investigators Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina Eur. Heart J., December 2, 2003; 24(24): 2206 - 2212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Blann, S. Nadar, and G. Y.H. Lip Pharmacological Modulation of Platelet Function in Hypertension Hypertension, July 1, 2003; 42(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Boutitie, F. Gueyffier, S. Pocock, R. Fagard, J. P. Boissel, and for the INDANA Project Steering Committee J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data Ann Intern Med, March 19, 2002; 136(6): 438 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A Meredith and P. Trenkwalder Therapy in the elderly hypertensive Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1_suppl): S49 - S56. [Abstract] [PDF]
|
|
|
|
|
|
N. Miyai, M. Arita, K. Miyashita, I. Morioka, T. Shiraishi, and I. Nishio Blood Pressure Response to Heart Rate During Exercise Test and Risk of Future Hypertension Hypertension, March 1, 2002; 39(3): 761 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Glynn, G. J. L'Italien, H. D. Sesso, E. A. Jackson, and J. E. Buring Development of Predictive Models for Long-Term Cardiovascular Risk Associated With Systolic and Diastolic Blood Pressure Hypertension, January 1, 2002; 39(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Black, W. J. Elliott, M. A. Weber, W. H. Frishman, J. A. Strom, P. R. Liebson, C. T. Hwang, D. A. Ruff, R. Montoro, V. DeQuattro, et al. One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension Hypertension, November 1, 2001; 38(5): 1118 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-C. Su, J.-S. Jeng, K.-L. Chien, F.-C. Sung, H.-C. Hsu, and Y.-T. Lee Hypertension Status Is the Major Determinant of Carotid Atherosclerosis: A Community-Based Study in Taiwan Stroke, October 1, 2001; 32(10): 2265 - 2271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. U. Chae, R. T. Lee, N. Rifai, and P. M. Ridker Blood Pressure and Inflammation in Apparently Healthy Men Hypertension, September 1, 2001; 38(3): 399 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Franklin, M. J. Jacobs, N. D. Wong, G. J. L'Italien, and P. Lapuerta Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US Hypertensives : Analysis Based on National Health and Nutrition Examination Survey (NHANES) III Hypertension, March 1, 2001; 37(3): 869 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Sesso, M. J. Stampfer, B. Rosner, C. H. Hennekens, J. M. Gaziano, J. E. Manson, and R. J. Glynn Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men Hypertension, November 1, 2000; 36(5): 801 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Voko, M. L. Bots, A. Hofman, P. J. Koudstaal, J. C. M. Witteman, and M. M. B. Breteler J-Shaped Relation Between Blood Pressure and Stroke in Treated Hypertensives Hypertension, December 1, 1999; 34(6): 1181 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Castellani, A. Ungar, C. Cantini, G. La Cava, C. Di Serio, B. Vallotti, A. Altobelli, and G. Masotti Impaired Renal Adaptation to Stress in the Elderly With Isolated Systolic Hypertension Hypertension, November 1, 1999; 34(5): 1106 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Levy, C. N. Bairey Merz, R. J. Cody, F. M. Fouad-Tarazi, C. K. Francis, M. A. Pfeffer, N. A. Scott, H. J. C. Swan, M. P. Taylor, and M. H. Weinberger Hypertension detection, treatment and control: A call to action for cardiovascular specialists J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1360 - 1362. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Singh, M. G. Larson, T. A. Manolio, C. J. O'Donnell, M. Lauer, J. C. Evans, and D. Levy Blood Pressure Response During Treadmill Testing as a Risk Factor for New-Onset Hypertension : The Framingham Heart Study Circulation, April 13, 1999; 99(14): 1831 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. DeCarli, B. L. Miller, G. E. Swan, T. Reed, P. A. Wolf, J. Garner, L. Jack, and D. Carmelli Predictors of Brain Morphology for the Men of the NHLBI Twin Study Stroke, March 1, 1999; 30(3): 529 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gambassi, K. Lapane, A. Sgadari, F. Landi, P. Carbonin, A. Hume, L. Lipsitz, V. Mor, R. Bernabei, and for the SAGE Study Group Prevalence, Clinical Correlates, and Treatment of Hypertension in Elderly Nursing Home Residents Arch Intern Med, November 23, 1998; 158(21): 2377 - 2385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Berger, H. Schulte, F. Stogbauer, and G. Assmann Incidence and Risk Factors for Stroke in an Occupational Cohort : The PROCAM Study Stroke, August 1, 1998; 29(8): 1562 - 1566. [Abstract] [Full Text] [PDF]
|
|